DZIF-project-derived start-up “EBViously“ announces first details of its EBV vaccine candidate
EBViously, a spin-off from Helmholtz Munich (HMGU), is led by world-leading experts in Epstein-Barr virus biology, genetics, and immunity and was founded to develop a...